Cargando…

Association of Maternal Age to Development and Progression of Retinopathy of Prematurity in Infants of Gestational Age under 33 Weeks

Aim. To find predictive and indicative markers of risk for development of retinopathy of prematurity (ROP) and its progression to the stage requiring laser treatment, in premature infants whose gestational age (GA) was under 33 weeks. Methods. We retrospectively reviewed medical records of 197 prema...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchida, Atsuro, Miwa, Masayuki, Shinoda, Hajime, Koto, Takashi, Nagai, Norihiro, Mochimaru, Hiroshi, Tomita, Yohei, Sasaki, Mariko, Ikeda, Kazushige, Tsubota, Kazuo, Ozawa, Yoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021680/
https://www.ncbi.nlm.nih.gov/pubmed/24876945
http://dx.doi.org/10.1155/2014/187929
_version_ 1782316282748600320
author Uchida, Atsuro
Miwa, Masayuki
Shinoda, Hajime
Koto, Takashi
Nagai, Norihiro
Mochimaru, Hiroshi
Tomita, Yohei
Sasaki, Mariko
Ikeda, Kazushige
Tsubota, Kazuo
Ozawa, Yoko
author_facet Uchida, Atsuro
Miwa, Masayuki
Shinoda, Hajime
Koto, Takashi
Nagai, Norihiro
Mochimaru, Hiroshi
Tomita, Yohei
Sasaki, Mariko
Ikeda, Kazushige
Tsubota, Kazuo
Ozawa, Yoko
author_sort Uchida, Atsuro
collection PubMed
description Aim. To find predictive and indicative markers of risk for development of retinopathy of prematurity (ROP) and its progression to the stage requiring laser treatment, in premature infants whose gestational age (GA) was under 33 weeks. Methods. We retrospectively reviewed medical records of 197 premature infants born in 2005–2010 whose GA < 33 weeks and underwent eye screening at Keio University Hospital. The association between candidate risk factors and development or progression of ROP was assessed. Results. Among the 182 eligible infants (median GA, 29.1 weeks; median birth weight (BW), 1028 g), 84 (46%) developed any stage of ROP, of which 45 (25%) required laser treatment. Multivariate analysis using a stepwise method showed that GA (P = 0.002; 95% confidence interval (CI), 0.508–0.858), BW (P < 0.001; 95% CI, 0.994–0.998), and lower maternal age (P = 0.032; 95% CI, 0.819–0.991) were the risk factors for ROP development and GA (P < 0.001; 95% CI, 0.387–0.609) and lower maternal age (P = 0.012; 95% CI, 0.795–0.973) were for laser treatment. The odds ratio of requiring laser treatment was 3.3 when the maternal age was <33 years. Conclusion. ROP was more likely to be developed and progressed in infants born from younger mother and low GA.
format Online
Article
Text
id pubmed-4021680
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-40216802014-05-29 Association of Maternal Age to Development and Progression of Retinopathy of Prematurity in Infants of Gestational Age under 33 Weeks Uchida, Atsuro Miwa, Masayuki Shinoda, Hajime Koto, Takashi Nagai, Norihiro Mochimaru, Hiroshi Tomita, Yohei Sasaki, Mariko Ikeda, Kazushige Tsubota, Kazuo Ozawa, Yoko J Ophthalmol Clinical Study Aim. To find predictive and indicative markers of risk for development of retinopathy of prematurity (ROP) and its progression to the stage requiring laser treatment, in premature infants whose gestational age (GA) was under 33 weeks. Methods. We retrospectively reviewed medical records of 197 premature infants born in 2005–2010 whose GA < 33 weeks and underwent eye screening at Keio University Hospital. The association between candidate risk factors and development or progression of ROP was assessed. Results. Among the 182 eligible infants (median GA, 29.1 weeks; median birth weight (BW), 1028 g), 84 (46%) developed any stage of ROP, of which 45 (25%) required laser treatment. Multivariate analysis using a stepwise method showed that GA (P = 0.002; 95% confidence interval (CI), 0.508–0.858), BW (P < 0.001; 95% CI, 0.994–0.998), and lower maternal age (P = 0.032; 95% CI, 0.819–0.991) were the risk factors for ROP development and GA (P < 0.001; 95% CI, 0.387–0.609) and lower maternal age (P = 0.012; 95% CI, 0.795–0.973) were for laser treatment. The odds ratio of requiring laser treatment was 3.3 when the maternal age was <33 years. Conclusion. ROP was more likely to be developed and progressed in infants born from younger mother and low GA. Hindawi Publishing Corporation 2014 2014-04-30 /pmc/articles/PMC4021680/ /pubmed/24876945 http://dx.doi.org/10.1155/2014/187929 Text en Copyright © 2014 Atsuro Uchida et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Uchida, Atsuro
Miwa, Masayuki
Shinoda, Hajime
Koto, Takashi
Nagai, Norihiro
Mochimaru, Hiroshi
Tomita, Yohei
Sasaki, Mariko
Ikeda, Kazushige
Tsubota, Kazuo
Ozawa, Yoko
Association of Maternal Age to Development and Progression of Retinopathy of Prematurity in Infants of Gestational Age under 33 Weeks
title Association of Maternal Age to Development and Progression of Retinopathy of Prematurity in Infants of Gestational Age under 33 Weeks
title_full Association of Maternal Age to Development and Progression of Retinopathy of Prematurity in Infants of Gestational Age under 33 Weeks
title_fullStr Association of Maternal Age to Development and Progression of Retinopathy of Prematurity in Infants of Gestational Age under 33 Weeks
title_full_unstemmed Association of Maternal Age to Development and Progression of Retinopathy of Prematurity in Infants of Gestational Age under 33 Weeks
title_short Association of Maternal Age to Development and Progression of Retinopathy of Prematurity in Infants of Gestational Age under 33 Weeks
title_sort association of maternal age to development and progression of retinopathy of prematurity in infants of gestational age under 33 weeks
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021680/
https://www.ncbi.nlm.nih.gov/pubmed/24876945
http://dx.doi.org/10.1155/2014/187929
work_keys_str_mv AT uchidaatsuro associationofmaternalagetodevelopmentandprogressionofretinopathyofprematurityininfantsofgestationalageunder33weeks
AT miwamasayuki associationofmaternalagetodevelopmentandprogressionofretinopathyofprematurityininfantsofgestationalageunder33weeks
AT shinodahajime associationofmaternalagetodevelopmentandprogressionofretinopathyofprematurityininfantsofgestationalageunder33weeks
AT kototakashi associationofmaternalagetodevelopmentandprogressionofretinopathyofprematurityininfantsofgestationalageunder33weeks
AT nagainorihiro associationofmaternalagetodevelopmentandprogressionofretinopathyofprematurityininfantsofgestationalageunder33weeks
AT mochimaruhiroshi associationofmaternalagetodevelopmentandprogressionofretinopathyofprematurityininfantsofgestationalageunder33weeks
AT tomitayohei associationofmaternalagetodevelopmentandprogressionofretinopathyofprematurityininfantsofgestationalageunder33weeks
AT sasakimariko associationofmaternalagetodevelopmentandprogressionofretinopathyofprematurityininfantsofgestationalageunder33weeks
AT ikedakazushige associationofmaternalagetodevelopmentandprogressionofretinopathyofprematurityininfantsofgestationalageunder33weeks
AT tsubotakazuo associationofmaternalagetodevelopmentandprogressionofretinopathyofprematurityininfantsofgestationalageunder33weeks
AT ozawayoko associationofmaternalagetodevelopmentandprogressionofretinopathyofprematurityininfantsofgestationalageunder33weeks